Improvement of Movement Disorder and Neurodevelopment under Selegiline in a CLTC-Deficient Patient

Mov Disord Clin Pract. 2023 Jul 19;10(9):1430-1432. doi: 10.1002/mdc3.13834. eCollection 2023 Sep.

¹ Department of Human Neuroscience Sapienza University of Rome Rome Italy.
² Pediatric Intensive Care Unit Sapienza University of Rome Rome Italy.
³ Department of Oncology and Molecular Medicine Istituto Superiore di Sanità Rome Italy.

No abstract available

Keywords: CLTC deficiency; clathrin heavy chain polypeptide; clathrin‐coated vesicles; neurodevelopmental disorder; pediatric movement disorders.